Bruce Broussard, Former Humana CEO, Joins Navina Advisory Board to Support Growth Across Payers and Providers

Navina, the leading AI-powered clinical intelligence platform, today announced that Bruce Broussard, former CEO of Humana, has joined its advisory board. Broussard’s decades of experience in Medicare Advantage, combined with his track record in advancing integrated, outcomes-focused care models, will be instrumental as Navina continues to scale across providers and health plans.

Navina transforms patient outcomes with clinically grounded, agentic AI for healthcare enterprise workflows. By bringing clinical context from multiple, longitudinal sources, Navina creates the most accurate patient digital twin delivering real-time clinical intelligence and agentic automation from backoffice to point of care. With expertise in data reconciliation, healthcare ontologies, AI reasoning, and clinical workflows, Navina has demonstrated strong outcomes for value-based care organizations improving quality of care, enhancing financial performance, and reducing administrative burden.

"Meaningful improvement in patient outcomes comes down to having the complete clinical picture within every patient interaction, and the ability to drive the right action from it, automatically, at the moment of care. That's what Navina's clinician-first AI is designed to deliver,” said Ronen Lavi, CEO and Co-founder of Navina. “Bruce brings a strategic vision for where healthcare is heading that very few people in this industry have. That perspective, and his willingness to share it, will be invaluable as we partner with a growing number of health plans and provider organizations.”

Broussard served as CEO of Humana for more than a decade, where he led the company’s transformation into a value-based care leader, significantly expanding its Medicare Advantage business and advancing payer-provider integration. He brings deep expertise in aligning clinical outcomes with financial performance and scaling programs that depend on accurate, timely clinical data.

“AI is opening up a more practical way to improve outcomes, raise the quality of care, and manage costs. It helps turn data into something healthcare teams can actually use and brings it into the flow of how care gets delivered every day," said Broussard. "What stands out about Navina’s approach is how they’re putting real-time clinical insight directly in front of providers, so care can be more proactive and better coordinated. I’m looking forward to working with the team as they continue to scale that impact across the system.”

With high clinician adoption rates, Navina has helped shift traditionally cumbersome, retroactive workflows to the point of care. This reduces reliance on post-encounter activities that drive up costs and liability, while accelerating revenue realization and measurable improvements in risk adjustment accuracy, quality performance, and clinician satisfaction.

With the addition of Broussard to its advisory board, Navina continues to strengthen its leadership as it advances its mission to support more connected, proactive, data-driven care across providers and health plans.